NanoBioNexus - Enabling Point of Care Diagnostics With Innovative Nanotechnologies

11/29/2007

Life Sciences

Morrison & Foerster LLP
12531 High Bluff Drive, Suite 100
San Diego, CA 92130

Sponsorship

Fueled by prevailing trends in the healthcare industry, molecular diagnostics is now considered to be the fastest growing field in diagnostics becoming a $1.8 billion industry today. Its estimated growth rate in the next five years is 15-20%, reaching $4 billion by 2010. Mapping of the human genome has brought about breakthroughs in molecular diagnostics while threats of rampant infectious diseases such as SARS or the avian flu pandemic have raised the urgency for early, rapid and accurate detection of diseases. Join us to learn more about innovative nanotech-based diagnostics platforms and how these new technologies are designed to become a reality in the doctor’s office or be used in the field at the patient’s side.

To register, please go to http://www.nanobionexus.org

Email Disclaimer

Unsolicited e-mails and information sent to Morrison & Foerster will not be considered confidential, may be disclosed to others pursuant to our Privacy Policy, may not receive a response, and do not create an attorney-client relationship with Morrison & Foerster. If you are not already a client of Morrison & Foerster, do not include any confidential information in this message. Also, please note that our attorneys do not seek to practice law in any jurisdiction in which they are not properly authorized to do so.

©1996-2018 Morrison & Foerster LLP. All rights reserved.